Cannabis firm Rua Bioscience targets October NZX listing

Cannabis firm Rua Bioscience targets October NZX listing
Brent Melville
Medicinal cannabis firm Rua Bioscience has signalled it will head to the NZX this October, breaking an initial public offering drought that has persisted since Napier Port listed in August last year.Chair Trevor Burt said the East Coast-based cannabis company, one of the first in New Zealand to be licensed for commercial production, is aiming for an IPO in the latter part of the year, “subject to market conditions and other company developments.”He said while the number of shares and price range are “yet to be decided,&rd...

More Markets

NZ sharemarket enjoys good week with fourth gain
Markets Market close

NZ sharemarket enjoys good week with fourth gain

The S&P/NZX 50 Index closed at 11,938.08, up 64.04 points or 0.54%.

Graham Skellern 03 May 2024
BHP CEO flies to South Africa to push $65.4 billion takeover
Markets

BHP CEO flies to South Africa to push $65.4 billion takeover

The executives have already begun conversations with key stakeholders.

Bloomberg 03 May 2024
Rakon shareholder wants light shed on $400m bid
Markets

Rakon shareholder wants light shed on $400m bid

US giant Skyworks could be Rakon's new owner. One shareholder wants it to confirm.